Cancer charities have condemned a decision not to licence a drug being trialled in our region which extends the life of women suffering the advanced stages of breast cancer.
The National Institute for Clinical Excellence - or NICE - says the drug "Perjeeta" isn't cost effective.
Perjeeta is currently being tested on women through the Christie Hospital in Manchester - but it isn't routinely available on the NHS.
Cancer charities and women taking the drug want NICE to reconsider .
Ashley Derricott reports.
More top news
Unsettled and turning windier over the Bank Holiday weekend. Mixed going forward...
Very mixed weekend - best day Saturday - windiest and wettest on Monday
This is the unbelievable moment a pedestrian in Manchester, comes inches from being mown down by a biker.